PAROXETINE HYDROCHLORIDE | A078902 | MYLAN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.0991
per ea
Lowest NADAC/Unit
$0.0625
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00378700310PAROXETINE HCL 30 MG TABLET | $0.0991 | EA | Generic | — | 2026-10-21 |
| 00378700393PAROXETINE HCL 30 MG TABLET | $0.0991 | EA | Generic | — | 2026-10-21 |
| 00378700493PAROXETINE HCL 40 MG TABLET | $0.0979 | EA | Generic | — | 2026-10-21 |
| 00378700410PAROXETINE HCL 40 MG TABLET | $0.0979 | EA | Generic | — | 2026-10-21 |
| 00378700193PAROXETINE HCL 10 MG TABLET | $0.0634 | EA | Generic | — | 2026-10-21 |
| 00378700110PAROXETINE HCL 10 MG TABLET | $0.0634 | EA | Generic | — | 2026-10-21 |
| 00378700210PAROXETINE HCL 20 MG TABLET | $0.0625 | EA | Generic | — | 2026-10-21 |
| 00378700293PAROXETINE HCL 20 MG TABLET | $0.0625 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.